Suvorexant
Use attributes for filter ! | |
Molar mass | 450. 92 g/mol |
---|---|
Formula | C23H23ClN6O2 |
Other names | MK-4305 |
Trade name | Belsomra |
Elimination half-life | ~12 hours |
Metabolism | CYP3A |
CYP2C19 | |
Music groups | Ramelteon |
Eszopiclone | |
Zolpidem | |
Date of Reg. | |
Date of Upd. | |
ID | 2951261 |
About Suvorexant
Suvorexant, sold under the trade name Belsomra, is a medication for the treatment of insomnia. It is effective for insomnia, at least for four weeks and as compared to a placebo. Suvorexant is a selective, dual orexin receptor antagonist made by Merck & Co.